BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6339742)

  • 1. Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
    Allhoff EP; Proppe KH; Chapman CM; Lin CW; Prout GR
    J Urol; 1983 Feb; 129(2):315-8. PubMed ID: 6339742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
    Epstein JI; Eggleston JC
    Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of immunocytochemistry in diagnosis of prostatic neoplasia by fine needle aspiration biopsy.
    Katz RL; Raval P; Brooks TE; Ordóñez NG
    Diagn Cytopathol; 1985; 1(1):28-32. PubMed ID: 2424683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study.
    Keillor JS; Aterman K
    J Urol; 1987 May; 137(5):894-6. PubMed ID: 2437333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
    Milani M; Tacconi R; Marsili G; Trognoni A; Centioni G; Leoni T; Fumarola A
    Quad Sclavo Diagn; 1986 Dec; 22(4):428-32. PubMed ID: 2445000
    [No Abstract]   [Full Text] [Related]  

  • 7. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
    Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
    Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic origin of tumors. An immunohistochemical study.
    Nadji M; Tabei SZ; Castro A; Chu TM; Morales AR
    Am J Clin Pathol; 1980 Jun; 73(6):735-9. PubMed ID: 6156593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of prostatic acid phosphatase.
    Yam LT; Janckila AJ; Lam WK; Li CY
    Prostate; 1981; 2(1):97-107. PubMed ID: 7024961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical diagnosis of the metastasizing prostatic carcinoma.
    Steffens J; Friedmann W; Lobeck H
    Eur Urol; 1985; 11(2):91-4. PubMed ID: 2408895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostatic acid phosphatase, beta-glucuronidase and prostate specific antigen assays in fine needle aspirates from benign and malignant prostates.
    Erickson DR; Hlavinka TC; Rockwood AP; Metter JD; Novicki DE; Fried MG
    J Urol; 1991 Nov; 146(5):1402-7. PubMed ID: 1719247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic epithelial polyp of the urethra.
    Eglen DE; Pontius EE
    J Urol; 1984 Jan; 131(1):120-2. PubMed ID: 6361281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB].
    Morishita N; Minami Y; Ogawa S; Saito Y
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):404-13. PubMed ID: 6206268
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
    Bauer HW; Schmeller NT
    Urology; 1984 Mar; 23(3):247-51. PubMed ID: 6199879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay].
    Fuse H; Akimoto S; Shimazaki J
    Hinyokika Kiyo; 1986 Dec; 32(12):1813-9. PubMed ID: 2435130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical diagnosis of metastasizing prostatic carcinomas].
    Friedmann W; Steffens J; Lobeck H
    Onkologie; 1984 Dec; 7(6):337-41. PubMed ID: 6084838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of carcinoid-like metastatic prostatic carcinoma by an immunoperoxidase method.
    Ansari MA; Pintozzi RL; Choi YS; Ladove RF
    Am J Clin Pathol; 1981 Jul; 76(1):94-8. PubMed ID: 7020410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
    Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
    J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical identification of prostatic acid phosphatase and prostate specific antigen in female periurethral glands.
    Pollen JJ; Dreilinger A
    Urology; 1984 Mar; 23(3):303-4. PubMed ID: 6199882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.